
National Research Corporation NRC
$ 18.79
4.19%
Quarterly report 2025-Q3
added 11-07-2025
National Research Corporation P/S Ratio 2011-2026 | NRC
Annual P/S Ratio National Research Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.79 | 7.51 | 7.15 | 8.51 | 13.4 | 8.88 | 7.64 | 3.81 | 3.57 | 3.4 | 4.04 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.4 | 3.4 | 6.79 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
8.09 | $ 21.01 | 8.92 % | $ 99.4 M | ||
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
6.87 | $ 22.01 | 11.81 % | $ 237 M | ||
|
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
5.13 | $ 5.72 | 2.88 % | $ 168 M | ||
|
BioNano Genomics
BNGO
|
0.115 | $ 1.62 | 1.89 % | $ 2.06 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M | ||
|
DarioHealth Corp.
DRIO
|
2.13 | $ 12.64 | 20.15 % | $ 359 M | ||
|
DexCom
DXCM
|
13.5 | $ 67.67 | 1.7 % | $ 26.1 B | ||
|
Castle Biosciences
CSTL
|
2.14 | $ 38.51 | -0.08 % | $ 1.07 B | ||
|
Exact Sciences Corporation
EXAS
|
3.38 | $ 101.53 | -0.21 % | $ 18.8 B | ||
|
Danaher Corporation
DHR
|
6.37 | $ 234.56 | 1.82 % | $ 171 B | ||
|
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | ||
|
Fulgent Genetics
FLGT
|
1.65 | $ 25.48 | -0.43 % | $ 770 M | ||
|
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | ||
|
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
1.86 | $ 20.02 | 4.6 % | $ 1.08 B | ||
|
Anixa Biosciences
ANIX
|
0.337 | $ 3.18 | 0.63 % | $ 101 K | ||
|
IQVIA Holdings
IQV
|
2.31 | $ 233.99 | 3.82 % | $ 42.4 B | ||
|
Guardant Health
GH
|
7.91 | $ 102.55 | 0.79 % | $ 12.6 B | ||
|
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | ||
|
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | ||
|
Illumina
ILMN
|
3.75 | $ 140.15 | 4.32 % | $ 22.3 B | ||
|
Charles River Laboratories International
CRL
|
2.11 | $ 208.19 | 2.86 % | $ 10.7 B | ||
|
Myriad Genetics
MYGN
|
1.16 | $ 6.19 | 0.73 % | $ 561 M | ||
|
NeoGenomics
NEO
|
2.31 | $ 12.18 | 3.53 % | $ 1.54 B | ||
|
Neogen Corporation
NEOG
|
1.14 | $ 7.3 | 4.21 % | $ 1.58 B | ||
|
Natera
NTRA
|
6.47 | $ 235.89 | 3.08 % | $ 23.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 173.85 | 0.13 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
1.29 | $ 6.05 | -6.35 % | $ 785 M | ||
|
OPKO Health
OPK
|
6.61 | $ 1.26 | -0.39 % | $ 874 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.62 | $ 253.05 | 0.55 % | $ 21.2 B | ||
|
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
3.25 | $ 197.18 | 4.51 % | $ 16.3 B | ||
|
IDEXX Laboratories
IDXX
|
9.66 | $ 682.72 | 1.9 % | $ 56.3 B | ||
|
Lantheus Holdings
LNTH
|
4.21 | $ 69.25 | 2.94 % | $ 4.79 B | ||
|
Pacific Biosciences of California
PACB
|
7.05 | $ 1.96 | 6.52 % | $ 497 M | ||
|
Agilent Technologies
A
|
6.64 | $ 142.17 | 3.08 % | $ 43.2 B | ||
|
Mettler-Toledo International
MTD
|
7.72 | $ 1 439.83 | 2.01 % | $ 30.6 B | ||
|
Organovo Holdings
ONVO
|
21.5 | - | -2.3 % | $ 19.4 M | ||
|
Biomerica
BMRA
|
1.35 | $ 2.56 | 1.19 % | $ 5.88 M |